Compare · BEN vs HQL
BEN vs HQL
Side-by-side comparison of Franklin Templeton Inc. (BEN) and abrdn Life Sciences Investors Shares of Beneficial Interest (HQL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BEN and HQL operate in Investment Managers (Finance), so they compete in similar markets.
- BEN is the larger of the two at $16.08B, about 33.9x HQL ($473.5M).
- Over the past year, BEN is up 39.9% and HQL is up 5.4% - BEN leads by 34.5 points.
- BEN has hit the wire 16 times in the past 4 weeks while HQL has been quiet.
- BEN has more recent analyst coverage (25 ratings vs 0 for HQL).
- Company
- Franklin Templeton Inc.
- abrdn Life Sciences Investors Shares of Beneficial Interest
- Price
- $31.95+0.96%
- $18.05-2.54%
- Market cap
- $16.08B
- $473.5M
- 1M return
- -2.59%
- +2.04%
- 1Y return
- +39.91%
- +5.40%
- Industry
- Investment Managers
- Investment Managers
- Exchange
- NYSE
- NYSE
- IPO
- 1992
- News (4w)
- 16
- 0
- Recent ratings
- 25
- 0
Franklin Templeton Inc.
Franklin Resources, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships. It launches equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. The firm invests in the public equity, fixed income, and alternative markets. Franklin Resources, Inc. was founded in 1947 and is based in San Mateo, California with an additional office in Hyderabad, India.
abrdn Life Sciences Investors Shares of Beneficial Interest
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Latest BEN
- Benefit Street Partners Announces Closing of a $1.1 Billion CRE CLO
- Franklin Templeton Launches Two ETFs Combining U.S. Equities and Bitcoin Through Systematic Dividend Reinvestment
- Fiduciary Trust International Welcomes Jeffrey Danile as National Director of Trust Administration
- ChinaAMC and Franklin Templeton Sign Strategic MOU to Deepen Cross-Border Collaboration
- Andrew “Drew” Chan Joins Fiduciary Trust International as Senior Portfolio Manager in Los Angeles Office
- Franklin Templeton Canada Announces ETF Cash Distributions
- Affiliate of Investment Adv. Franklin Templeton Inc sold $5,000,000 worth of shares (441,696 units at $11.32) (SEC Form 4)
- SEC Form 4 filed by Franklin Resources Inc.
- SEC Form 4 filed by Franklin Resources Inc.
- SEC Form 4 filed by Franklin Resources Inc.
Latest HQL
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Director Mahai Chris Lavictoire bought $10,498 worth of shares (527 units at $19.92) (SEC Form 4)
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form 3 filed by new insider Mahai Chris Lavictoire
- SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details